Answer to Question 1
ANS: D
Acarbose is excreted in breast milk and should not be administered to nursing mothers. Acarbose is contraindicated for use in pregnancy.
Answer to Question 2
ANS: B
Lipohypertrophy, or fatty thickening of the lipid tissues, slows insulin absorption and is best pre-vented by rotation of injection sites. It is triggered by the insulin, which stimulates fat synthesis.